- Home
- EDAP
EDAP
EDAP TMS S.A.
as 04-18-2025 1:35pm EST
| Founded: | 1979 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 1997 |
| Target Price: | $8.50 | AVG Volume (30 days): | 285.2K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.26 - $7.73 | Next Earning Date: | 05-15-2025 |
| Revenue: | $66,378,507 | Revenue Growth: | 6.11% |
| Revenue Growth (this year): | 0.74% | Revenue Growth (next year): | 0.37% |
Latest EDAP TMS S.A. News
EDAP Breaking Stock News: Dive into EDAP Ticker-Specific Updates for Smart Investing
MT Newswires
15 days ago
--Jefferies Downgrades EDAP TMS SA to Hold From Buy, Adjusts Price Target to $2 From $8
Simply Wall St.
21 days ago
EDAP TMS Full Year 2024 Earnings: Beats Expectations
GuruFocus.com
22 days ago
Edap TMS SA (EDAP) Q4 2024 Earnings Call Highlights: Strong HIFU Growth Amidst Strategic Shifts
GlobeNewswire
23 days ago
EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results
GlobeNewswire
a month ago
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
GlobeNewswire
2 months ago
EDAP Appoints Glen French to Board of Directors
GlobeNewswire
2 months ago
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
Simply Wall St.
3 months ago
EDAP TMS (NASDAQ:EDAP) investors are sitting on a loss of 68% if they invested three years ago
Compare EDAP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EDAP EDAP TMS S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.